Matches in Wikidata for { <http://www.wikidata.org/entity/Q57807330> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q57807330 description "article scientifique publié en 2018" @default.
- Q57807330 description "article" @default.
- Q57807330 description "artículu científicu" @default.
- Q57807330 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57807330 description "wetenschappelijk artikel" @default.
- Q57807330 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57807330 name "Tildrakizumab: A Review of Phase II and III Clinical Trials" @default.
- Q57807330 name "Tildrakizumab: A Review of Phase II and III Clinical Trials" @default.
- Q57807330 type Item @default.
- Q57807330 label "Tildrakizumab: A Review of Phase II and III Clinical Trials" @default.
- Q57807330 label "Tildrakizumab: A Review of Phase II and III Clinical Trials" @default.
- Q57807330 prefLabel "Tildrakizumab: A Review of Phase II and III Clinical Trials" @default.
- Q57807330 prefLabel "Tildrakizumab: A Review of Phase II and III Clinical Trials" @default.
- Q57807330 P1433 Q57807330-30B935A7-F01C-472B-A373-3B1732D4E74A @default.
- Q57807330 P1476 Q57807330-227FF863-F0A4-41A3-BE32-5445EE6C1E1F @default.
- Q57807330 P2093 Q57807330-41955C87-22BC-47FD-BA92-8BCCB79B1BA9 @default.
- Q57807330 P2093 Q57807330-6C45674C-DDAB-49F9-B022-0CEF8CA6D2F1 @default.
- Q57807330 P2093 Q57807330-ED26C9CC-59F1-4631-8FB6-A2DC09F9ABC2 @default.
- Q57807330 P2093 Q57807330-FAC7371B-10FA-4A88-A4E6-89D1ACB3BB8C @default.
- Q57807330 P304 Q57807330-F00B5E17-7255-4E73-9759-1B3291FBAAC6 @default.
- Q57807330 P31 Q57807330-0B4571A3-ECB1-415D-9BFC-2D8AA02304AB @default.
- Q57807330 P356 Q57807330-F71749D5-A2B6-4F60-B7BD-E68632B6069B @default.
- Q57807330 P407 Q57807330-BABDE395-C270-4A65-8CFF-468F628F9B08 @default.
- Q57807330 P433 Q57807330-60286299-8371-4B04-A285-797D510DC5D7 @default.
- Q57807330 P478 Q57807330-CC087B74-7CC2-4BA7-9F20-26447F158E32 @default.
- Q57807330 P50 Q57807330-194E2349-9A44-4ECE-8FD4-3D6008FC061D @default.
- Q57807330 P577 Q57807330-A82544A2-6BAF-463B-9ED0-27819CE1B8E2 @default.
- Q57807330 P698 Q57807330-716E6D9D-A38B-4BEB-8208-1A32DC9EF13D @default.
- Q57807330 P921 Q57807330-0EECF86F-AF88-4CBD-9A73-C417736EC4ED @default.
- Q57807330 P356 1060028018809522 @default.
- Q57807330 P698 30345790 @default.
- Q57807330 P1433 Q4767858 @default.
- Q57807330 P1476 "Tildrakizumab: A Review of Phase II and III Clinical Trials" @default.
- Q57807330 P2093 "Adrian Pona" @default.
- Q57807330 P2093 "Sarah D Gabros" @default.
- Q57807330 P2093 "Sree S Kolli" @default.
- Q57807330 P2093 "Steven R Feldman" @default.
- Q57807330 P304 "413-418" @default.
- Q57807330 P31 Q13442814 @default.
- Q57807330 P356 "10.1177/1060028018809522" @default.
- Q57807330 P407 Q1860 @default.
- Q57807330 P433 "4" @default.
- Q57807330 P478 "53" @default.
- Q57807330 P50 Q64513735 @default.
- Q57807330 P577 "2018-10-20T00:00:00Z" @default.
- Q57807330 P698 "30345790" @default.
- Q57807330 P921 Q42824440 @default.